Village Farms International, Inc. (VFF), a top-10 global cannabis operator by market capitalization at approximately $350 million, outlined its growth strategy during the iAccess Alpha Virtual Best Ideas Fall Investment Conference in September 2026. The company, which reported trailing 12-month sales of around $290 million, highlighted a 15% revenue growth rate and a disciplined approach to expansion, capital allocation, and international market penetration.
The company’s cash position stands at CAD 73 million, with net cash of CAD 33 million as of Q2 2026. Institutional ownership rose to 25% following a CAD 15 million equity placement in June 2026, while insider ownership remains at about 10% of shares outstanding. Village Farms’ P/E ratio is 15.93, reflecting its market valuation amid a competitive sector.
A key strategic move was the privatization of its legacy produce business in May 2024, generating CAD 40 million in proceeds and leaving the company with a 37.9% equity stake in Verdexa Holdings. This transition reduced annual produce revenue from Delta-1 to between CAD 20 million and CAD 25 million. The company’s Q2 net income was impacted by a CAD 20 million gain from the prior-year sale, offsetting operational costs.
Capital expenditures for 2026 totaled CAD 15 million, directed toward expanding cultivation capacity. The company also paid CAD 17 million in Canadian income taxes and CAD 31 million in excise taxes, alongside a CAD 7 million stock buyback. These outlays reflect Village Farms’ focus on operational efficiency and shareholder returns.
Internationally, Village Farms operates a 7.2 million-square-foot cultivation footprint, with the Delta, British Columbia campus—its largest single-site EU GMP-certified facility—covering 4.8 million square feet, of which 2.2 million are dedicated to cannabis. The D3 and D2 facilities alone generate over CAD 200 million in trailing 12-month sales, producing around 160 tons of dried cannabis annually. A D2 expansion, nearing completion, will add about 40 metric tons annually, boosting Canadian capacity by roughly 33% over the next six months.
In the U.S., West Texas assets—50 acres of advanced greenhouse infrastructure—could unlock a potential $400 million revenue stream if fully converted to cannabis production. In Europe, the Netherlands facility’s Phase 2 ramp-up will reach 10 tons by Q1 2027. Meanwhile, the company targets four new international markets in 2026, following regulatory approvals and testing, with Germany leading its medical market presence. Pricing in the Netherlands, where Village Farms holds one of 10 adult-use licenses, exceeds €10 per gram.
The Canadian cannabis market, valued at around CAD 6 billion and growing at mid-single-digit rates, has been profitable since legalization in 2017. Village Farms’ Canadian operations maintain gross margins of 30% to 40%, though recent international product contributions have pushed margins above this range. Strains across its platform consistently test at mid-20s to low-30s percent THC levels. Management expects continued profitability and expansion, driven by disciplined asset deployment and strategic international expansion.
